Biology and therapy of urological cancer metastasis.
作者信息
Posadas Edwin M, McConkey David J, Chung Leland W K
机构信息
Samuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Medical Center, Los Angeles, CA, USA.
Johns Hopkins Greenberg Bladder Cancer Institute, Department of Urology, Brady Urological Institute, Johns Hopkins University, Baltimore, MD, USA.
出版信息
Asian J Urol. 2016 Oct;3(4):167-169. doi: 10.1016/j.ajur.2016.09.008. Epub 2016 Sep 23.
Abstract
摘要
相似文献
1
Biology and therapy of urological cancer metastasis.泌尿系统癌症转移的生物学与治疗
Asian J Urol. 2016 Oct;3(4):167-169. doi: 10.1016/j.ajur.2016.09.008. Epub 2016 Sep 23.
2
Advances in angiogenesis research: relevance to urological oncology.血管生成研究进展：与泌尿外科肿瘤学的相关性
J Urol. 1997 Nov;158(5):1663-74. doi: 10.1016/s0022-5347(01)64090-4.
3
Recent advances in extracellular vesicle research for urological cancers: From technology to application.近年来泌尿系统癌症细胞外囊泡研究的进展：从技术到应用。
Biochim Biophys Acta Rev Cancer. 2019 Apr;1871(2):342-360. doi: 10.1016/j.bbcan.2019.01.008. Epub 2019 Feb 7.
4
High incidence of urological complications in men dying from prostate cancer.死于前列腺癌的男性泌尿系统并发症发生率高。
Int J Clin Oncol. 2016 Dec;21(6):1150-1154. doi: 10.1007/s10147-016-0993-x. Epub 2016 Jun 4.
5
[Home hospice care for the urological cancer patients].[泌尿外科癌症患者的居家临终关怀护理]
Gan To Kagaku Ryoho. 2011 Dec;38 Suppl 1:73-5.
6
Shared Decision-Making for Patients with Advanced Urological Malignancies: Evaluation of a Joint Urological-Oncological Clinic Model.晚期泌尿系统恶性肿瘤患者的共同决策：联合泌尿外科-肿瘤学临床模式的评估。
Oncol Res Treat. 2019;42(7-8):366-374. doi: 10.1159/000499721. Epub 2019 Jun 6.
7
Surgical management of bone metastases from urological malignancies: an analysis of 70 cases.泌尿生殖系统恶性肿瘤骨转移的外科治疗：70例分析
Acta Orthop Traumatol Turc. 2015;49(6):634-40. doi: 10.3944/AOTT.2015.14.0340.
8
Is sperm banking of interest to patients with nongerm cell urological cancer before potentially fertility damaging treatments?对于患有非生殖细胞泌尿系统癌症的患者，在可能损害生育能力的治疗之前，精子库是否值得关注？
J Urol. 2009 Sep;182(3):1101-7. doi: 10.1016/j.juro.2009.05.026. Epub 2009 Jul 18.
9
External validation of European Organization for Research and Treatment of Cancer and Spanish Urological Club for Oncological Treatment scoring models to predict recurrence and progression in Japanese patients with non-muscle invasive bladder cancer treated with bacillus Calmette-Guérin.欧洲癌症研究与治疗组织及西班牙肿瘤治疗泌尿学俱乐部评分模型的外部验证，用于预测接受卡介苗治疗的日本非肌层浸润性膀胱癌患者的复发和进展情况。
Int J Urol. 2014 Dec;21(12):1201-7. doi: 10.1111/iju.12572. Epub 2014 Jul 30.
10
Chemotherapy for metastatic testicular cancer: The first nationwide multi-institutional study by the Cancer Registration Committee of the Japanese Urological Association.转移性睾丸癌的化疗：日本泌尿外科学会癌症登记委员会的首个全国性多机构研究。
Int J Urol. 2018 Aug;25(8):730-736. doi: 10.1111/iju.13720. Epub 2018 Jul 17.
本文引用的文献
1
Metastasis in renal cell carcinoma: Biology and implications for therapy.肾细胞癌中的转移：生物学及其对治疗的影响。
Asian J Urol. 2016 Oct;3(4):286-292. doi: 10.1016/j.ajur.2016.08.006. Epub 2016 Aug 30.
2
Developing immunotherapy strategies in the treatment of prostate cancer.开发用于治疗前列腺癌的免疫治疗策略。
Asian J Urol. 2016 Oct;3(4):278-285. doi: 10.1016/j.ajur.2016.08.008. Epub 2016 Aug 30.
3
Novel immunotherapy approaches for metastatic urothelial and renal cell carcinoma.转移性尿路上皮癌和肾细胞癌的新型免疫治疗方法。
Asian J Urol. 2016 Oct;3(4):268-277. doi: 10.1016/j.ajur.2016.08.013. Epub 2016 Sep 6.
4
Intrinsic subtypes and bladder cancer metastasis.内在亚型与膀胱癌转移
Asian J Urol. 2016 Oct;3(4):260-267. doi: 10.1016/j.ajur.2016.09.009. Epub 2016 Sep 23.
5
Applications of circulating tumor cells for prostate cancer.循环肿瘤细胞在前列腺癌中的应用。
Asian J Urol. 2016 Oct;3(4):254-259. doi: 10.1016/j.ajur.2016.09.004. Epub 2016 Sep 14.
6
Cultured circulating tumor cells and their derived xenografts for personalized oncology.用于个性化肿瘤学的培养循环肿瘤细胞及其衍生的异种移植瘤
Asian J Urol. 2016 Oct;3(4):240-253. doi: 10.1016/j.ajur.2016.08.005. Epub 2016 Aug 25.
7
Specific bone region localization of osteolytic versus osteoblastic lesions in a patient-derived xenograft model of bone metastatic prostate cancer.在骨转移性前列腺癌的患者来源异种移植模型中溶骨性与成骨性病变的特定骨区域定位。
Asian J Urol. 2016 Oct;3(4):229-239. doi: 10.1016/j.ajur.2016.09.001. Epub 2016 Sep 12.
8
Mismatch repair enzyme expression in primary and castrate resistant prostate cancer.错配修复酶在原发性及去势抵抗性前列腺癌中的表达
Asian J Urol. 2016 Oct;3(4):223-228. doi: 10.1016/j.ajur.2016.09.002. Epub 2016 Sep 12.
9
Understanding the biology of urothelial cancer metastasis.了解尿路上皮癌转移的生物学机制。
Asian J Urol. 2016 Oct;3(4):211-222. doi: 10.1016/j.ajur.2016.09.005. Epub 2016 Sep 14.
10
The evolving landscape of prostate cancer stem cell: Therapeutic implications and future challenges.前列腺癌干细胞的演变态势：治疗意义与未来挑战
Asian J Urol. 2016 Oct;3(4):203-210. doi: 10.1016/j.ajur.2016.09.006. Epub 2016 Sep 20.
Zotero 插件